As you approach regulatory submission, having a technologically advanced partner to steer you through is crucial.
Your journey is moving from drug development to commercialization, and you need a team with long-standing expertise in both. You need an integrated phase IIIb-IV team of development and commercialization specialists with global and local market insight, a team with a proven track record of advancing new drugs through late phase clinical trials, compassionate use studies and real world studies, rigorously compiling data to satisfy multiple stakeholders – regulatory agencies, physicians and payers, to name a few. PAREXEL® has provided world class Late Phase services for over a decade. This is why we know this part of your journey so well. We helped plan it.